MediWound announces the publication of its Phase III Children Innovative Debridement Study (CIDS) for pediatric burns. The study findings reinforce NexoBrid’s clinical benefits as a rapid, effective and non-surgical alternative for eschar...
MediWound announces the publication of its Phase III Children Innovative Debridement Study (CIDS) for pediatric burns. The study findings reinforce NexoBrid’s clinical benefits as a rapid, effective and non-surgical alternative for eschar...
MediWound announces the...